Home > Ammonium hypophosphite > Ammonium hypophosphite(7803-65-8)
Ammonium hypophosphite(7803-65-8)
Supplier Product Identification
Physical and Chemical Properties
First Aid Measures
Handling and Storage
Hazards Identification
Exposure Controls/Personal Protection
Fire Fighting Measures
Accidental Release Measures
Stability and Reactivity
Product Identification
Product Name
Ammonium hypophosphite
Ammonium hypophosphite
Synonyms
Ammonium phosphinate
Ammonium phosphinate
CAS
7803-65-8
7803-65-8
Formula
H6NO2P
H6NO2P
Molecular Weight
83.03
83.03
EINECS
232-266-0
232-266-0
Merck
12,559
12,559
Beilstein/Gmelin
180889 (G)
180889 (G)
Physical and Chemical Properties
Appearance
White crystalline solid.
White crystalline solid.
Solubility in water
1 g/1 ml
1 g/1 ml
Melting Point
200
200
Density
1.634 g/cm3
1.634 g/cm3
Usage
Catalyst in polyamide mfr.
Catalyst in polyamide mfr.
First Aid Measures
Ingestion
The possible benefit of early removal of some ingested material by cautious gastric lavage must be weighed against potential complications of bleeding or perforation. Activated charcoal activated charcoal binds most toxic agents and can decrease their systemic absorption if administered soon after ingestion. Activated charcoal: administer charcoal as a slurry (240 ml water/30 g charcoal). Usual dose: 25 to 100 g in adults/adolescents.
The possible benefit of early removal of some ingested material by cautious gastric lavage must be weighed against potential complications of bleeding or perforation. Activated charcoal activated charcoal binds most toxic agents and can decrease their systemic absorption if administered soon after ingestion. Activated charcoal: administer charcoal as a slurry (240 ml water/30 g charcoal). Usual dose: 25 to 100 g in adults/adolescents.
Inhalation
Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with beta2 agonist and corticosteroid aerosols.
Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with beta2 agonist and corticosteroid aerosols.
Skin
Treatment should include recommendations listed in the oral exposure section when appropriate.
Treatment should include recommendations listed in the oral exposure section when appropriate.
Eyes
If symptoms develop, immediately move individual away from exposure and into fresh air. Flush eyes gently with water for at least 15 minutes while holding eyelids apart; seek immediate medical attention.
If symptoms develop, immediately move individual away from exposure and into fresh air. Flush eyes gently with water for at least 15 minutes while holding eyelids apart; seek immediate medical attention.
Handling and Storage
Storage
Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.
Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.
Handling
All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
Hazards Identification
Inhalation
Mucous membrane irritation, shortness of breath, cough, sputum production chest tightness, dyspnea, ards, and delayed onset of pulmonary edema may occur.
Mucous membrane irritation, shortness of breath, cough, sputum production chest tightness, dyspnea, ards, and delayed onset of pulmonary edema may occur.
Skin
Sweating and cyanosis have been seen.
Sweating and cyanosis have been seen.
Eyes
Irritation of the mucous membranes may be noted.
Irritation of the mucous membranes may be noted.
Ingestion
Nausea, vomiting, abdominal pain, and diarrhea may occur.
Nausea, vomiting, abdominal pain, and diarrhea may occur.
Exposure Controls/Personal Protection
Personal Protection
Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots.
Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots.
Respirators
Use NIOSH/MSHA approved respirator appropriate for exposure of concern.
Use NIOSH/MSHA approved respirator appropriate for exposure of concern.
Exposure Effects
Rapid heart rate and abnormally low blood pressure may occur. Dizziness, headache, fatigue, stupor, restlessness, ataxia, seizures, and coma may be noted. No data were available to assess the teratogenic potential of this agent. <br>Decreased egg production has occurred in experimental animals. Ammonia crosses the ovine placental barrier. <br>No data were available to assess the potential effects of exposure to this agent during lactation. <br>No information about possible male reproductive effects was found in available references.
Rapid heart rate and abnormally low blood pressure may occur. Dizziness, headache, fatigue, stupor, restlessness, ataxia, seizures, and coma may be noted. No data were available to assess the teratogenic potential of this agent. <br>Decreased egg production has occurred in experimental animals. Ammonia crosses the ovine placental barrier. <br>No data were available to assess the potential effects of exposure to this agent during lactation. <br>No information about possible male reproductive effects was found in available references.
Fire Fighting Measures
Fire Fighting
Fire Extinguishing Agents: Carbon dioxide, dry chemical, or water spray
Fire Extinguishing Agents: Carbon dioxide, dry chemical, or water spray
Fire Potential
Decomposes when heated with evolution of phosphine which ignites spontaneously.
Decomposes when heated with evolution of phosphine which ignites spontaneously.
Accidental Release Measures
Small spills/leaks
Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces.
Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces.
Stability and Reactivity
Stability
No data.
No data.
Combustion Products
Decomposes at 240 emitting phosphine and PO x.
Decomposes at 240 emitting phosphine and PO x.
Contact
More
- Company Name:J & K SCIENTIFIC LTD.
- Tel:010-82848833 400-666-7788
- Fax:86-10-82849933
- WebSite:http://www.jkchemical.com
- Company Name:Meryer (Shanghai) Chemical Technology Co., Ltd.
- Tel:021-61259108 18621169109
- Fax:86-21-61259102
- WebSite:https://www.meryer.com/cn/index/
- Company Name:3B Pharmachem (Wuhan) International Co.,Ltd.
- Tel:821-50328103-801 18930552037
- Fax:86-21-50328109
- WebSite:https://www.chemicalbook.com/ShowSupplierProductsList13285/0.htm
- Company Name:Beijing HwrkChemical Technology Co., Ltd
- Tel:010-89508211 18501085097
- Fax:010-89508210
- WebSite:http://www.hwrkchemical.com
- Company Name:Beijing Ouhe Technology Co., Ltd
- Tel:010-82967028 13552068683
- Fax:+86-10-82967029
- WebSite:http://www.ouhechem.com/